Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, opened its 27th dispensary in Florida at 3631 NW Federal Highway in Jensen Beach on Friday, November 15th. Curaleaf has the largest cannabis dispensary footprint in the US with 50 dispensaries across the country and continues to execute on its strategy of rapid expansion in Florida.
The new 4,500 square foot location is accessible to patients from the Jensen Beach area, including the communities of Jupiter, Port St. Lucie, Stuart, Port Salerno and Palm City, and will offer a full range of premium quality medical cannabis products and private consultations by meticulously trained staff.
“We have been hearing from patients about the need for a full-service medical cannabis center along the Martin County and St. Lucie County coast,” said Joe Lusardi, Curaleaf CEO. “Curaleaf is proud to be the first dispensary in Jensen Beach, and we look forward to serving this community.”
Curaleaf will be launching a series of weekly seminars on cannabinoids for local patients, physicians and community members in Jensen Beach, and team members will be available for free private consultations for new patients who need assistance registering with Florida’s Department of Health. The State of Florida’s Office of Medical Marijuana Use Registry requires an order from a qualified Florida ordering physician and a State of Florida medical marijuana card to obtain medical marijuana products.
In an effort to improve patient accessibility to medical cannabis, Curaleaf offers a wide range of standing discounts. Curaleaf also offers all patients free statewide delivery as well as online ordering for pick-up or delivery through www.curaleaf.com. Jensen Beach area patients may contact the dispensary at 772-934-9575.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is the leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 50 dispensaries, 14 cultivation sites and 13 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.
For more information please visit www.curaleaf.com.